AETHLON MEDICAL INC - 8-K Filing

Aethlon Medical reports Q2 fiscal 2027 results and announces merger agreement with North Immunology, Inc. (Items: 2.02 Results of Operations and Financial Condition, 7.01 of this Current Report, including Exhibit 99, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $AEMD

Read the full article at SEC EDGAR

More Regulatory news